{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T22:40:07Z","timestamp":1790980807607,"version":"4.1.0"},"reference-count":45,"publisher":"Wiley","issue":"7","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1972,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1111\/j.1478-3231.2010.02256.x","type":"journal-article","created":{"date-parts":[[2010,5,27]],"date-time":"2010-05-27T06:49:36Z","timestamp":1274942976000},"page":"969-978","source":"Crossref","is-referenced-by-count":42,"title":["Antifibrotic and fibrolytic properties of celecoxib in liver damage induced by carbon tetrachloride in the rat"],"prefix":"10.1111","volume":"30","author":[{"given":"Enrique","family":"Ch\u00e1vez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9","family":"Segovia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mineko","family":"Shibayama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor","family":"Tsutsumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula","family":"Vergara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis","family":"Castro-S\u00e1nchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo P\u00e9rez","family":"Salazar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario G.","family":"Moreno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pablo","family":"Muriel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2010,4,8]]},"reference":[{"key":"10.1111\/j.1478-3231.2010.02256.x-BIB1|cit1","first-page":"1052","article-title":"Hepatic fibrogenesis in response to chronic liver injury","volume":"28","author":"Svegliati-Baroni","year":"2008","journal-title":"novel insights on the role of cell-to-cell interaction and transition"},{"key":"10.1111\/j.1478-3231.2010.02256.x-BIB2|cit2","first-page":"371","volume-title":"Hepatotoxicity: from Genomics to in vitro and in vivo Models","author":"Muriel","year":"2008"},{"key":"10.1111\/j.1478-3231.2010.02256.x-BIB3|cit3","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1111\/j.1582-4934.2006.tb00292.x","article-title":"Modern pathogenic concepts of liver fibrosis suggest stellate cells and TGF \u03b2 as major players and therapeutics targets","volume":"10","author":"Gressner","year":"2006","journal-title":"J Cell Mol Med"},{"key":"10.1111\/j.1478-3231.2010.02256.x-BIB4|cit4","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1146\/annurev.pharmtox.38.1.97","article-title":"Cyclooxygenases 1 and 2","volume":"38","author":"Vane","year":"1998","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1111\/j.1478-3231.2010.02256.x-BIB5|cit5","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1006\/bbrc.2000.3496","article-title":"Functional coupling of cyclooxygenase 1 and 2 to discrete prostanoid synthases in liver macrophages","volume":"276","author":"Dieter","year":"2000","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1111\/j.1478-3231.2010.02256.x-BIB6|cit6","first-page":"350","article-title":"Distribution of constitutive (COX-1) and inducible (COX-2) cyclooxygenase in postviral human liver cirrhosis","volume":"57","author":"Mohammed","year":"2004","journal-title":"a possible role for COX-2 in the pathogenesis of liver cirrhosis"},{"key":"10.1111\/j.1478-3231.2010.02256.x-BIB7|cit7","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1053\/gast.1997.v112.pm9041257","article-title":"Enhanced cyclooxygenase-2 gene expression in alcoholic liver disease in the rat","volume":"112","author":"Nanji","year":"1997","journal-title":"Gastroenterology"},{"key":"10.1111\/j.1478-3231.2010.02256.x-BIB8|cit8","doi-asserted-by":"crossref","first-page":"193","DOI":"10.3346\/jkms.2002.17.2.193","article-title":"NF-kappa B binding activity and cyclooxygenase-2 expression in persistent CCl(4)-treated rat liver injury","volume":"17","author":"Kim","year":"2002","journal-title":"J Korean Med Sci"},{"key":"10.1111\/j.1478-3231.2010.02256.x-BIB9|cit9","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.cellbi.2006.11.018","article-title":"A selective cyclooxygenase-2 inhibitor decreases transforming growth factor-\u03b21 synthesis and matrix production in human peritoneal mesothelial cells","volume":"31","author":"Liu","year":"2007","journal-title":"Cell Biol Int"},{"key":"10.1111\/j.1478-3231.2010.02256.x-BIB10|cit10","doi-asserted-by":"crossref","first-page":"2334","DOI":"10.1046\/j.1523-1755.2000.00093.x","article-title":"A selective cyclooxygenase-2 inhibitor decreases proteinuria and retards progressive renal injury in rats","volume":"57","author":"Wang","year":"2000","journal-title":"Kidney Int"},{"key":"10.1111\/j.1478-3231.2010.02256.x-BIB11|cit11","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/S0016-5085(03)00904-1","article-title":"JTE-522, a cyclooxygenase-2 inhibitor, is an effective chemopreventive agent against rat experimental liver fibrosis","volume":"1252","author":"Yamamoto","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1111\/j.1478-3231.2010.02256.x-BIB12|cit12","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1093\/ajcp\/28.1.56","article-title":"A colorimetric method for determination of serum oxaloacetic and glutamic pyruvic transaminases","volume":"28","author":"Reitman","year":"1957","journal-title":"Am J Clin Pathol"},{"key":"10.1111\/j.1478-3231.2010.02256.x-BIB13|cit13","first-page":"269","volume-title":"Methods of Enzymatic Analysis","author":"Bergmeyer","year":"1983"},{"key":"10.1111\/j.1478-3231.2010.02256.x-BIB14|cit14","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/0014-5793(72)80075-9","article-title":"Glutamyl transferase in kidney brush border membranes","volume":"19","author":"Glossman","year":"1972","journal-title":"FEBS Lett"},{"key":"10.1111\/j.1478-3231.2010.02256.x-BIB15|cit15","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/0003-2697(79)90738-3","article-title":"Assay for lipid peroxides in animal tissues by the thiobarbituric acid reaction","volume":"95","author":"Okawa","year":"1979","journal-title":"Anal Biochem"},{"key":"10.1111\/j.1478-3231.2010.02256.x-BIB16|cit16","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/0003-2697(76)90527-3","article-title":"A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein dye binding","volume":"72","author":"Bradford","year":"1976","journal-title":"Anal Biochem"},{"key":"10.1111\/j.1478-3231.2010.02256.x-BIB17|cit17","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/0003-2697(60)90050-6","article-title":"A specific method for the analysis of hydroxyproline in tissues and urine","volume":"1","author":"Prockop","year":"1960","journal-title":"Anal Biochem"},{"key":"10.1111\/j.1478-3231.2010.02256.x-BIB18|cit18","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/0003-2697(76)90326-2","article-title":"A fluorometric method for determination of oxidized and reduced glutathione in tissues","volume":"74","author":"Hissin","year":"1976","journal-title":"Anal Biochem"},{"key":"10.1111\/j.1478-3231.2010.02256.x-BIB19|cit19","first-page":"191","article-title":"The estimation of glycogen with the anthrone reagent","volume":"25","author":"Seifter","year":"1950","journal-title":"Arch Biochem"},{"key":"10.1111\/j.1478-3231.2010.02256.x-BIB20|cit20","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1078\/0065-1281-00591","article-title":"Biochemical and histochemical analysis of 71 kDa dystrophin isoform (Dp71f) in rat brain","volume":"103","author":"Garcia-Tovar","year":"2001","journal-title":"Acta Histochem"},{"key":"10.1111\/j.1478-3231.2010.02256.x-BIB21|cit21","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/0003-2697(80)90338-3","article-title":"Electrophoretic analysis of plasminogen activators in polyacrylamide gels containing sodium dodecyl sulfate and copolymerized substrates","volume":"102","author":"Heussen","year":"1980","journal-title":"Anal Biochem"},{"key":"10.1111\/j.1478-3231.2010.02256.x-BIB22|cit22","first-page":"603","article-title":"Ethanol stimulates the secretion of matrix metalloproteinases 2 and 9 in MCF-7 human breast cancer cells","volume":"15","author":"Etique","year":"2006","journal-title":"Oncol Rep"},{"key":"10.1111\/j.1478-3231.2010.02256.x-BIB23|cit23","doi-asserted-by":"crossref","first-page":"7","DOI":"10.4161\/cbt.8.17.9199","article-title":"Anti-inflammatory, anti-proliferative and antioxidant profiles of selective cyclooxygenase-2 inhibition as chemoprevention for rat bladder carcinogenesis","volume":"8","author":"Parada","year":"2009","journal-title":"Cancer Biol Ther"},{"key":"10.1111\/j.1478-3231.2010.02256.x-BIB24|cit24","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1159\/000113885","article-title":"Intracellular effects of NSAIDs\/ASA in oxidatively stressed human lens epithelial cells in culture","volume":"40","author":"Petersen","year":"2008","journal-title":"Ophthalmic Res"},{"key":"10.1111\/j.1478-3231.2010.02256.x-BIB25|cit25","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1016\/S0022-5347(05)65933-2","article-title":"Does cyclooxygenase-2 inhibitor prevent renal tissue damage in unilateral obstruction?","volume":"166","author":"Miyajima","year":"2001","journal-title":"J Urol"},{"key":"10.1111\/j.1478-3231.2010.02256.x-BIB26|cit26","first-page":"1665","article-title":"Increased intrahepatic cyclooxygenase 2, matrix metalloproteinase 2, and matrix metalloproteinase 9 expression is associated with progressive liver disease in chronic hepatitis C virus infection","volume":"53","author":"N\u00fa\u00f1ez","year":"2004","journal-title":"role of viral core and NS5A proteins"},{"key":"10.1111\/j.1478-3231.2010.02256.x-BIB27|cit27","first-page":"183","article-title":"Prostaglandin E2 enhances transforming growth factor-beta 1 and TGF-beta receptors synthesis","volume":"74","author":"Ramirez-Ya\u00f1ez","year":"2006","journal-title":"an in vivo and in vitro study"},{"key":"10.1111\/j.1478-3231.2010.02256.x-BIB28|cit28","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1111\/j.1432-1033.1993.tb18468.x","article-title":"Glycogenolytic and antiglycogenolytic prostaglandin E2 actions in rat hepatocytes are mediated via different signalling pathways","volume":"218","author":"P\u00fcschel","year":"1993","journal-title":"Eur J Biochem"},{"key":"10.1111\/j.1478-3231.2010.02256.x-BIB29|cit29","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1055\/s-2001-17556","article-title":"Matrix as a modulator of hepatic fibrogenesis","volume":"21","author":"Schuppan","year":"2001","journal-title":"Semin Liver Dis"},{"key":"10.1111\/j.1478-3231.2010.02256.x-BIB30|cit30","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1111\/j.1478-3231.2006.01271.x","article-title":"Cytokine blockade inhibits hepatic tissue inhibitor of metalloproteinase-1 expression and up-regulates matrix metalloproteinase-9 in toxic liver injury","volume":"26","author":"Roderfeld","year":"2006","journal-title":"Liver Int"},{"key":"10.1111\/j.1478-3231.2010.02256.x-BIB31|cit31","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1042\/CS20030098","article-title":"Expression and coordinated regulation of matrix metalloproteinases in chronic hepatitis C and hepatitis C virus-induced liver cirrhosis","volume":"105","author":"Lichtinghagen","year":"2003","journal-title":"Clin Sci (Lond)"},{"key":"10.1111\/j.1478-3231.2010.02256.x-BIB32|cit32","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1159\/000084626","article-title":"Matrix metalloproteinases 2 and 9 are markers of inflammation but not of the degree of fibrosis in chronic hepatitis C","volume":"71","author":"Reif","year":"2005","journal-title":"Digestion"},{"key":"10.1111\/j.1478-3231.2010.02256.x-BIB33|cit33","first-page":"380","article-title":"Expression of matrix metalloproteinase-2 and -14 persists during early resolution of experimental liver fibrosis and might contribute to fibrolysis","volume":"26","author":"Zhou","year":"2006","journal-title":"Liver Int"},{"key":"10.1111\/j.1478-3231.2010.02256.x-BIB34|cit34","doi-asserted-by":"crossref","first-page":"4820","DOI":"10.1074\/jbc.M310999200","article-title":"Essential role of matrix metalloproteinases in interleukin-1-induced myofibroblastic activation of hepatic stellate cell in collagen","volume":"279","author":"Han","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1111\/j.1478-3231.2010.02256.x-BIB35|cit35","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/j.jhep.2007.02.003","article-title":"Expression of MMPs and TIMPs in liver fibrosis - a systematic review with special emphasis on anti-fibrotic strategies","volume":"46","author":"Hemmann","year":"2007","journal-title":"J Hepatol"},{"key":"10.1111\/j.1478-3231.2010.02256.x-BIB36|cit36","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/0-387-26476-0_12","volume-title":"Fibrogenesis: Cellular and Molecular Basis","author":"Okazaki","year":"2005"},{"key":"10.1111\/j.1478-3231.2010.02256.x-BIB37|cit37","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/j.1478-3231.2008.01760.x","article-title":"The anti-inflammatory effect of celecoxib does not prevent liver fibrosis in bile duct-ligated rats","volume":"29","author":"Yu","year":"2009","journal-title":"Liver Int"},{"key":"10.1111\/j.1478-3231.2010.02256.x-BIB38|cit38","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/j.1478-3231.2005.01202.x","article-title":"Effect of celecoxib on experimental liver fibrosis in rat","volume":"26","author":"Hui","year":"2006","journal-title":"Liver Int"},{"key":"10.1111\/j.1478-3231.2010.02256.x-BIB39|cit39","first-page":"305","article-title":"Prolonged bile duct obstruction","volume":"65","author":"Kountouras","year":"1984","journal-title":"a new experimental model for cirrhosis in the rat"},{"key":"10.1111\/j.1478-3231.2010.02256.x-BIB40|cit40","first-page":"375","article-title":"Resolution of liver fibrosis in chronic CCl4 administration in the rat after discontinuation of treatment","volume":"96","author":"Muriel","year":"2005","journal-title":"effect of silymarin, silibinin, colchicine and trimethylcolchicinic acid"},{"key":"10.1111\/j.1478-3231.2010.02256.x-BIB41|cit41","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1096\/fj.00-0716fje","article-title":"Celecoxib loses its anti-inflammatory efficacy at high doses through activation of NF-\u03baB","volume":"15","author":"Niederberger","year":"2001","journal-title":"FASEB J"},{"key":"10.1111\/j.1478-3231.2010.02256.x-BIB42|cit42","first-page":"1921","article-title":"Anti-inflammatory and upper gastrointestinal effects of celecoxib in rheumatoid arthritis","volume":"282","author":"Simon","year":"1999","journal-title":"a randomized controlled trial"},{"key":"10.1111\/j.1478-3231.2010.02256.x-BIB43|cit43","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1096\/fj.04-2753fje","article-title":"The selective cyclooxygenase-2 inhibitor SC-236 reduces liver fibrosis by mechanisms involving non-parenchymal cell apoptosis and PPARgamma activation","volume":"19","author":"Planagum\u00e0","year":"2005","journal-title":"FASEB J"},{"key":"10.1111\/j.1478-3231.2010.02256.x-BIB44|cit44","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1093\/carcin\/15.6.1279","article-title":"Prevention by acetylsalicylic acid of liver cirrhosis and carcinogenesis as well as generations of 8-hydroxydeoxyguanosine and thiobarbituric acid-reactive substances caused by a choline-deficient, l-amino acid-defined diet in rats","volume":"15","author":"Denda","year":"1994","journal-title":"Carcinogenesis"},{"key":"10.1111\/j.1478-3231.2010.02256.x-BIB45|cit45","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1136\/gut.2008.157420","article-title":"Celecoxib induces hepatic stellate cell apoptosis through inhibition of Akt activation and suppresses hepatic fibrosis in rats","volume":"58","author":"Paik","year":"2009","journal-title":"Gut"}],"container-title":["Liver International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1478-3231.2010.02256.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1478-3231.2010.02256.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,7]],"date-time":"2021-07-07T13:00:58Z","timestamp":1625662858000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1478-3231.2010.02256.x"}},"subtitle":["Celecoxib prevents and reverses liver fibrosis"],"short-title":[],"issued":{"date-parts":[[2010,4,8]]},"references-count":45,"journal-issue":{"issue":"7"},"URL":"https:\/\/doi.org\/10.1111\/j.1478-3231.2010.02256.x","relation":{},"ISSN":["1478-3223","1478-3231"],"issn-type":[{"value":"1478-3223","type":"print"},{"value":"1478-3231","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,4,8]]}}}